CellPoint
Founded 2018
The Netherlands
49 employees
Biotechnology, Health Care
The Netherlands
49 employees
Biotechnology, Health Care
General Information
Get notified when CellPoint moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CellPoint
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
The Netherlands Market
Biotechnology
About CellPoint
No funding data available for CellPoint yet.
Get notified when CellPoint raises fundingCellPoint Alternatives & Competitors
CellPoint vs
Abound Bio
United States
#PioneeringForPatients | A Galapagos company
3 employees
Biotechnology, Health Care
CellPoint vs
Galapagos
Belgium
Galapagos is now Lakefront Biotherapeutics. Follow our official new page for future updates.
693 employees
CellPoint vs
FAQ About CellPoint
CellPoint enables clinicians to treat hematological malignancies by retargeting patient immune cells at the point-of-care.
In 2022, CellPoint was acquired by Galapagos, a fully integrated biotechnology company. Since then, they have been united around a single purpose: to transform patient outcomes...
CellPoint was founded in 2018.
CellPoint is headquartered in The Netherlands.
CellPoint operates in the following industries: Biotechnology, Health Care.
CellPoint has approximately 49 employees.
Top alternatives and competitors to CellPoint include Abound Bio, Galapagos, Metsera, The Ian Martin Group, FEP Search Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CellPoint and Abound Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors CellPoint and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.